| Literature DB >> 36232467 |
Imre Hegedüs1, Kitti Andreidesz2, József L Szentpéteri3, Zoltán Kaleta4,5, László Szabó6, Krisztián Szigeti1, Balázs Gulyás7, Parasuraman Padmanabhan7, Ferenc Budan3,8, Domokos Máthé1,9.
Abstract
Nutritional interventions may highly contribute to the maintenance or restoration of human health. Grapes (Vitis vinifera) are one of the oldest known beneficial nutritional components of the human diet. Their high polyphenol content has been proven to enhance human health beyond doubt in statistics-based public health studies, especially in the prevention of cardiovascular disease and cancer. The current review concentrates on presenting and classifying polyphenol bioactive molecules (resveratrol, quercetin, catechin/epicatechin, etc.) available in high quantities in Vitis vinifera grapes or their byproducts. The molecular pathways and cellular signaling cascades involved in the effects of these polyphenol molecules are also presented in this review, which summarizes currently available in vitro and in vivo experimental literature data on their biological activities mostly in easily accessible tabular form. New molecules for different therapeutic purposes can also be synthesized based on existing polyphenol compound classes available in high quantities in grape, wine, and grape marc. Therefore an overview of these molecular structures is provided. Novel possibilities as dendrimer nanobioconjugates are reviewed, too. Currently available in vitro and in vivo experimental literature data on polyphenol biological activities are presented in easily accessible tabular form. The scope of the review details the antidiabetic, anticarcinogenic, antiviral, vasoprotective, and neuroprotective roles of grape-origin flavonoids. The novelty of the study lies in the description of the processing of agricultural by-products (grape seeds and skins) of industrial relevance, and the detailed description of the molecular mechanisms of action. In addition, the review of the clinical therapeutic applications of polyphenols is unique as no summary study has yet been done.Entities:
Keywords: anti-inflammatory; anticarcinogen; antidiabetic; antioxidant; flavonoids; grape; polyphenols; vasoprotective
Mesh:
Substances:
Year: 2022 PMID: 36232467 PMCID: PMC9570270 DOI: 10.3390/ijms231911165
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1General structure of polyphenols.
Main groups of polyphenols.
| Compound Group | General Structural Formula | Function | Representatives | |
|---|---|---|---|---|
| Flavonoids | Anthocyanidins |
| Plant dyes | Cyanidine |
| Flavonols |
| Inhibitors of drug-metabolizing enzymes | Quercetin | |
| Flavanols |
| The building blocks of proanthocyanides | Catechin, epicatechin | |
| Isoflavonoids |
| Immune booster, estrogen stimulator | Isoflavone, genistein | |
| Flavons |
| Stimulates the function of cytochrome p450 | Apigenin | |
| Flavonones |
| Antidiabetics | Hesperetin, Naringenin, Eriodictyol | |
| Stilbenoid | Stilbene |
| Antioxidant | Resveratrol |
Most important physiologically active compounds of the polyphenol fraction isolated from grape marc (grape seeds and grape skins).
| Source | Compound Name | Classification | Structural Formula | Function |
|---|---|---|---|---|
| Grape seed and skin | Cyanidin | Anthocyanidin |
| Oxygen radical sequestration |
| Catechin/Epicatechin | Catechins flavan-3-ol |
| Anticancer | |
| Quercetin | Flavonol |
| Anti-inflammatory | |
| Whole grapes | Resveratrol | Fitoalexin |
| Antioxidant |
| Rutin | Quercetin-3-rutinozide, flavonoid |
| Anti-inflammatory |
Physical properties of the main monomeric components of polyphenols.
| Physical Properties | Catechin | EC | EGC |
|---|---|---|---|
| Molecular weight (Mr) | 293 | 294 | 445 |
| Melting point, °C | 174 | 236 | 236 |
| Optical rotation, degree | 0° | 58.3° | 188° |
| Amax | 264–280 nm | ||
Methods used for the determination of antioxidant content.
| Title | Method | Materials Needed | Literature |
|---|---|---|---|
| Antioxidant activity determination | FRAP method | FeCl3, triazine | [ |
| András Boór total antioxidant content | 2,4,6-Tris(2-pyridyl)-s-triazine | [ | |
| Determination of total polyphenol content | Folin Ciocalteu Reagent, | [ | |
| Free radical scavenging activity (antiradical activity) | 1,1-Diphenyl-2-picrylhydrazine | [ | |
| Determination of anthocyanin content | Dilution at 550 nm with 96% ethanol containing 2% HCL at 2% | [ | |
| Determination of leucoanthocyanins | spectrophotometrically after heating with a 40:60 mixture of hydrochloric acid and butanol containing ferrous sulphate | [ | |
| Determination of catechin content | reacted with sulphuric acid vanillin in an alcohol-diluted solution at 500 nm by spectrophotometry | Vanillin | [ |
| Resveratrol content determination | directly to HPLC | [ |
Antioxidant and free radical scavenging properties of polyphenols isolated from grape marc (grape seeds and grape skins).
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|
| Epigallocatechin, | Lipoxygenase and cyclooxygenase inhibition | Human colon mucosa and tumor tissue | In vitro | [ |
| EGCG, | ARE 3-mediated gene expression through activation of MAPK 4 proteins (ERK, JNK, P38) | Hep G2 ARE in C8 cells | In vitro | [ |
| Catechin, | Increases CAT 5, GST 6 and SOD 7 activity, increases intracellular GSH 8 levels | Heart H9C2 cells | In vitro | [ |
| EGCG, Quercetin, ECG | Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase | Rat brain F0F1 ATPase | In vitro | [ |
| (-)-epicatechin, procyanidin, EGCG, ECG | The recombinant human platelet | J774A-1 cells | In vitro | [ |
| Resveratrol | Inhibition of O-acyltransferase and sulfotransferase activity | Ovine ovarian tissue | In vitro | [ |
| Inhibition of H2O2 production and PMO activity | Mouse skin | Ex vivo | [ | |
| Quercetin | Inhibits LDH cleavage | HepG2 cells | In vitro | [ |
| MDA and lipoperoxidation coupling | Rooster semen | In vitro | [ | |
| Increasing the expression and activity of NQO1 11 | MCF 7 in human breast cancer cells | In vitro | [ | |
| γ-GCS 12 level increase | Central neuron cells | In vitro | [ | |
| Increasing ARE binding activity and transcriptional activity regulated by NRF2 13 | Human B lymphoma cells | In vitro | [ | |
| Reduction of PhIP-DNA adduct formation catalysed by O-acyl transferase and sulfotransferase | Primary culture of human mammary epithelial and adipose cells | In vitro | [ | |
| Inhibits the expression and activity of CYP1A1/1A2 15 | In microsomes and intact Hep G2 cells | In vitro | [ | |
| Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase | Caco-2 cell line | In vitro | [ |
1 Epigallocatechin gallate; 2 Epicatechin gallate; 3 Antioxidant Response Elements (ARE); 4 Mitogen activated protein kinase; 5 catalase; 6 Glutathione S-transferase; 7 Superoxide dismutase; 8 Glutathione; 9 Glutathione peroxidase; 10 Glutathione reductase; 11 NADPH quinone oxidoreductase 1; 12 γ-glutamyl-cysteine synthetase; 13 NRF2 erythroid nuclear factor 2; 14 NRF2-Kelch-like ECH-associated protein 1; 15 Cytochrome P450-dependent monooxygenase 1A1 and 1A2.
Anti-atherosclerotic and cardioprotective effects of polyphenols isolated from grape marc (grape seeds and grape skins).
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|
| Resveratrol | Inhibition of MMP-9 1 expression and activity | Cisplatin-resistant human | In vitro | [ |
| Promotion of myocardial vessel formation by induction of VEGF 2, Trx-1 3 and HO-1 4 | H9C2 cells | In vitro | [ | |
| Inhibition of the expression and binding activity of MCP-1 5 and CCR2 6 receptors | Endometriotic stomal cells | In vitro | [ | |
| Increase NO and NOS levels | U2OS cells | In vitro | [ | |
| Reduces monocyte cell adhesion to stimulated endothelium | Human vascular endothelial cells | In vitro | [ | |
| EC | 7β-OH inhibition of cholesterol formation | Smooth muscle cells | In vitro | [ |
| Quercetin | Increase serum LDL-bound PON-1 10 levels | HuH7 in human liver cell line | In vitro | [ |
| Induction of IFN-γ 11 gene expression | Peripheral blood in Human Peripheral-blood CD4+ T cells | In vitro | [ | |
| Increase in intracellular GSH levels and activation of the γ-GCS 13 heavy subunit (GCS(h)) promoter | Central neuron cell line | In vitro | [ | |
| Genistein | They are incorporated into LDL, increasing its resistance to oxidation and its effectiveness in inhibiting cell proliferation | Human colon cancer cell line | Ex vivo, in vitro | [ |
| EGCG, EGC | Inhibition of rat VSMC 14 precipitation on collagen and laminin | Rat VSMC | In vitro | [ |
| Procyanidins | Reducing the leukotriene-to-prostacyclin ratio in blood plasma | Human aortic endothelial cells | In vitro | [ |
| Proanthocyanidin | Inhibition of CD36 mRNA expression | THP-1 cells | In vitro | [ |
1 Matrix metalloproteinase 2; 2 Vascular endothelial growth factor; 3 Thioredoxin-1; 4 Hem oxygenase-1; 5 Monocyte chemotactic protein-1; 6 Chemokine receptor-2; 7 Pitvar natriuretic peptide; 8 Brain natriuretic peptide; 9 Vascular cell adhesion molecule-1; 10 Paraoxonase-1; 11 γ-interferon; 12 interleukin-4; 13 γ-glutamylcysteine synthetase; 14 Vascular smooth muscle cell.
The protective effects of polyphenols isolated from grape marc (grape seeds and skins) on the nervous system.
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref |
|---|---|---|---|---|
| Resveratrol | Stimulates AMP kinase activity | Neuro2a in cells and primary neurons; MC3T3-E1 cells and primary osteoblasts | In vitro | [ |
| Activation of phosphorylation of PKC | Rat hippocampal cell culture; endothelial cell culture | In vitro | [ | |
| Protection of dopaminergic neurons | Organotypic mid-brain slice culture; human umbilical vein endothelial cells | In vitro | [ | |
| EGCG, | Inhibition of IL-6, IL-8, VEGF and PGE2 2 production | Human astrocytoma U373MG cell culture | In vitro | [ |
| Attenuation of mitochondrial membrane potential rupture and release of CYT-C 5 | Rat PC12 cells; HeLa cell line | In vitro | [ | |
| Epicatechin | Protects neurons from programmed cell death induced by oxLDL 6 by inhibiting the activation of JNK, c-JUN and caspase-3 | Primer neuron cell culture | In vitro | [ |
1 Amyloid beta aggregation; 2 Prostaglandin E2; 3 Nuclear Factor-κB; 4 C-JUN terminal kinase; 5 Cytochrome c; 6 Oxidized LDL.
Anti-inflammatory effects of the polyphenol content of grape marc (grape seeds and skins).
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|
| Procyanidins | Inhibition of IL-1β transcription and secretion | ARPE-19 cells | In vitro | [ |
| EGCG, ECG | Inducing programmed cell death by activating caspases 3, 8 and 9 | Caco-2 cells | In vitro | [ |
| Inhibition of CD11b expression | HepG2 cells | In vitro | [ | |
| Resveratrol | Inhibition of caspase-3 stimulation and IL-1β -induced cleavage of PARP | SH-SY5Y cells | In vitro | [ |
| Inhibition of iNOS mRNA and protein expression by inhibiting NF-κB activation | murine microglial cell line N9 | In vitro | [ | |
| Activation of MAP kinase phosphatase | Prostate cells | In vitro | [ | |
| Quercetin | Blocking the expression of ICAM-1 1, VCAM-1, and E-selectin | HUVECs | In vitro | [ |
| Inhibition of THP-1 adhesion and VCAM-1 expression activation | ARPE-19 cells | In vitro | [ | |
| Inhibition of NO production and inhibition of iNOS 2 protein expression | hep | In vitro | [ | |
| Anthocyanins | Localization in endothelial cells | Caco-2 cells | In vitro | [ |
1 Intracellular adhesion molecule-1; 2 Inducible nitric oxide synthase.
Mutation-reducing/anti-cancer effects of the polyphenol content of grape marc (grape seeds and skins).
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|
| Resveratrol | Inhibition of cell proliferation and reduction of telomerase activity | Human cancer cell line HCT116 | In vitro | [ |
| Stimulation of the P53-dependent pathway of programmed cell death | Human lung adenocarcinoma cells A549 | In vitro | [ | |
| Inhibition of cell proliferation by interaction with the ERα 1-related PI3K pathway | Estrogen-sensitive MC3T3-E1 precursor cells | In vitro | [ | |
| Inhibition of COX-2 expression through inhibition of MAPKs and AP-1 activation | RAW 264.7 macrophages | In vitro | [ | |
| Reduction of expression of COX-1, COX-2, c-MYC, c-FOS, c-JUN, TGF-β 1 2 and TNF-α | Mucosal cell line | In vitro | [ | |
| Inhibits oncogenic diseases through inhibition of protein kinase CKII activity | Human breast cancer mcf-7 cells | In vitro | [ | |
| Inhibition of PKCα and PKCβI Ca2+-dependent activity | Smoth muscle cells | In vitro | [ | |
| Prevents the formation of NB 3-DNS and NB-Hb 4 adducts | Hemoglobin of mice | In vivo | [ | |
| Quercetin | Blocking EGFR tyrosine kinase activity | Xenografted NSCLC cells EGFR C797S mutation | In vitro | [ |
| Quercetin, | Inhibition of human CYP1A1 activity | O-deethylation of 7-ethoxyresorufin human lymphoblastoid TK6 cells | In vitro | [ |
| Quercetin | Interaction with glycoprotein P and regulation of BCRP/ABCG2 6 activity | In two different cell lines expressing BCRP | In vitro | [ |
| EGCG | Telomerase inhibition | In human cancer cells | In vitro | [ |
1 Estrogen receptor α; 2 Transformational growth factor 1; 3 Nitrobenzene; 4 Hemoglobin; 5 Diol epoxide 2; 6 ATP-binding cassette transporter for breast cancer resistance protein.
Effect of the polyphenol content of grape marc (grape seeds and skins) on signal transduction.
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|
| Proanthocyanidins | Accelerate programmed cell death by altering the cdki-cdk-cyclin cascade and reducing mitochondrial membrane potential through activation of cascade 3 | Human epidermoid carcinoma A431 cells | In vitro | [ |
| Quercetin | Inhibition of phosphorylation of JNK and P38 MRK by ROS 1-mediated signaling | Murine macrophage cell line RAW 264.7 | In vitro | [ |
| Actin/PKB and ERK1/2 signaling cascade to affect neuronal functionality | P19 neuronal cells | In vitro | [ | |
| Resveratrol | Inhibits monocyte NO, MAPK and PI3K-dependent CCR2 binding | Rat fibroblast-like synoviocyte RSC-364 cell line | In vitro | [ |
| Inhibit cardiac fibroblast division via NO-cGMP signaling | Rat heart in fibroblast culture | In vitro | [ | |
| Activates phase II genes through regulation of ARE/EpRE activation | Lung cancer cells | In vitro | [ |
1 Reactive oxygen species.
Effect of the polyphenol content of grape marc (grape seeds and grape skins) on endothelial cells and blood vessel walls.
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|
| EGCG, Quercetin | Inhibition of programmed cell death through regulation of BCL-2 and BAX | 3T3-L1 preadipocytes | In vitro | [ |
| Cy3G 1 | Increases eNOS expression and activity | Endothelial cell line | In vitro | [ |
| EGCG | Endothelium-dependent vasodilator effect | HUVEC | In vitro | [ |
| Increases the activity of eNOS | Calf aortic endothelial cells | In vitro | [ | |
| Catechins | Chicken CAM 2 angiogenin-like protein reduces angiogen-induced vascularization | In chicken cells | In vitro | [ |
| Proanthocya-nidin | Reducing VCAM-1 expression | Primary HUVEC | In vitro | [ |
| Procyanidine, | They inhibit the activity of ACE 3 | Two substrates | In vitro | [ |
1 Cyanidin-3-glucoside; 2 Chicken chorioallantoic (embryonic spinal cord) membrane; 3 Angiotensin-converting enzyme.
Effect of the polyphenol content of grape marc (grape seeds and skins) on diabetes.
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|
| EGCG, ECG | Inhibits SGLT1 and sodium-free GLUT | Polarized Caco-2 intestinal cells | In vitro | [ |
| Quercetin | Reduces blood sugar levels | Intestinal cell model | In vitro | [ |
| Tannin, anthocyanin | Inhibition of α-amylase and α-glucosidase | On 2-chloro-4-nitrophenyl-4-O-β-D-galactopyranosyl maltosyl substrate | In vitro | [ |
1 Na-dependent vitamin C transporter 1.
Effect of the polyphenol content of grape marc (grape seeds and skins) on the cell cycle.
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|
| Resveratrol | Stimulates P21 expression and arrests the cell cycle in G1 phase | A375SM malignant melanoma | In vitro | [ |
| Inhibition of cyclin D1/D2-cdk6 cyclin D1/D2-cdk4 cyclin E-cdk2 complexes | MCF7 cells | In vitro | [ | |
| Decreases cyclin D1/Cdk4 complex and stimulates expression of cyclin E and A | Melanoma cells | In vitro | [ | |
| Decrease the hyperphosphorylated form of pRb and increase the hypophosphorylated form of pRb | Embryonic rat heart cell line | In vitro | [ | |
| Proanthocyani dines | Inhibit expression of cyclin B1, D1, A1 and 𝛃-catenin | Human cancer cell lines | In vitro | [ |
| They stop the cell cycle in the G1-S phase | VMSC at human hepatocellular carcinoma cells | In vitro | [ |
Other bioactive effects of the polyphenol content of grape marc (grape seeds and skins).
| Type of Activity | Polyphenol Name | Molecular Mechanism of the Protective Effect | Cell Culture | Level | Ref. |
|---|---|---|---|---|---|
| Anti-HIV effect | Proanthocyanidins | Inhibits expression of the HIV-preventing chaperones CCR2b, CCR3, and CCR5. | Normal peripheral mononuclear cells | In vitro | [ |
| Sensory effect | Proanthocyanidins, | Enhancing VEGF expression | Pigment cell culture; retinal ARPE-19 cells | In vitro | [ |
| Liver protection | Genistein | Reduces experimental liver damage by preventing lipid peroxidation and enhancing the antioxidant system | Rat and Human hepatocyte-derived cell lines (ie HepG2 and Hep3B) | In vitro | [ |
In vivo experiments for investigations of healing effects of grape seed extract and its components in different diseases.
| Polyphenol Name | Molecular Mechanism of the Protective Effect | Target Organ/Disease | Type of Investigation | Biomarker | Animals | Ref. |
|---|---|---|---|---|---|---|
| Lipophilic Grape Seed Proanthocyanidin (LGSP) | Apoptosis via decreasing the expression of cyclin D1 and CDK 4 and increasing the expression of the tumor suppressors p21 and p27; activation of cleaved fragments of caspases 3, caspases 9, and PARP | PC3 Human Prostate Cancer Cell xenograft | xenograft model via oral gavage LGSP | Ki67 and cleaved caspase 3 immunostaining | PC3-derived mouse | [ |
| Grape Seed Proanthocyanidin (GSP) | GSP induces autophagy, and inhibition of autophagy increased apoptosis in HepG2 cells; inducing the phosphorylation of mitogen-activated protein kinase (MAPK) pathway-associated proteins (p-JNK, p-ERK and p-p38 MAPK); reduces the expression of survivin | HepG2 (human liver cancer cells)-derived xenografts | xenograft model via oral gavage GSP | Ki67 immunostaining | nude mouse | [ |
| Grape Seed Procyanidin | decrease the inflammation by PPAR-γ/COX-2 pathway | Pulmonary arterial hypertension model | treated with normoxia/cigarette smoke | mPAP, PVR, RVHI, WT%, and WA% was detected in the rats | Sprague Dawley rats | [ |
| Grape Seed Proanthocyanidin (GSP) | endothelial nitric oxide synthase expression in lung tissue and plasma NO level were increased; Ca2+ level in pulmonary arterial smooth muscle cell (PASMC) was decreased; transcription of inflammatory factors such as myeloperoxidase, interleukin (IL)-1β, IL-6 and tumor necrosis factor alpha (TNF-α) was down-regulated in lung tissue; nuclear factor-κB pathway was inhibited as IκBα was less phosphorylated; TNFα-induced PASMC overproliferation could be inhibited | Pulmonary arterial hypertension model | treated with monocrotaline | Haemodynamic index, mean pulmonary arterial pressure (mPAP), cardiac output (CO), pulmonary vessel resistance (PVR), right ventricular hypertrophy index (RVHI), WT%, WA%, pulmonary blood pressure NO assay, cytosolic Ca2+ detection | Sprague Dawley rats | [ |
| Grape Seed Proanthocyanidin (GSP) | promoted locomotor recovery, reduced neuronal apoptosis, increased neuronal preservation, and regulated microglial polarization; microglial polarization and prevents neuronal apoptosis, possibly by the TLR4-mediated NF-κB and PI3K/AKT signaling pathways | Spinal cord injury | T9 vertebral laminectomy | Locomotor Recovery Assessment; Terminal Deoxynucleotidyl Transferase dUTP Nick-End Labeling (TUNEL) Assay; Annexin V-FITC/PI Assays; NO assay, Immunofluorescence staining: NeuN, GFAP, CD86, CD206, p-NF-κB-p65, p-AKT | Sprague Dawley rats | [ |
| Red grape seed and skin extract | GSSE was effective in protecting dopamine neurons from 6-OHDA toxicity by reducing apoptosis, the level of reactive oxygen species (ROS) and inflammation; reducing the cleaved caspase-3 activity that helps inhibit 6-OHDA-induced mDA neuron death in a cellular model of PD; decreases ROS production induced by 6- | Parkinson’s disease | neurotoxin 6-hydroxydopamine (6-OHDA), which induces oxidative damage and mimics the degeneration of dopaminergic neurons observed in Parkinson’s disease | Immunostaining: MAP2, AB5622, r tyrosine hydroxylase, caspase-3, phosphorylated NF-kB p65; ROS assay, | mice | [ |
Clinical investigation of grape seed extract polyphenols as therapeutics against the most common diseases.
| Polyphenol Name | Molecular Mechanism of Therapeutic Effect | Target Organ/Disease | Type of Investigation | Biomarker | Patients | Ref. |
|---|---|---|---|---|---|---|
| Resveratrol | STAT3/HIF-1/VEGF pathway | Rheumatoid arthritis | Randomized controlled clinical trial | CRP, DAS28-ESR, ESR, IL-6, MMP-3, RF, TNF-α, ucOC | 100 | [ |
| Grape seed extract | Reduces FPG, TC, LDL cholesterol, and triglycerides levels; | Glycemic control | Randomized controlled clinical trial | serum TC, LDL, VLDL, HDL colesterol, triglycerides level | 50 | [ |
| Grape seed extract | Suppress lipoxygenase pathways; increase pro-inflammatory leukotrienes | Inflammation | Randomized controlled clinical trial | CRP, pro-inflammatory leukotrienes, cytokine pattern | 50 | [ |
| Grape seed extract | VEGF, anti-inflammatory activity through cytokines (TNF, IL-1, IL-6, IL-14), antibacterial activity, antioxidant activity | Wound healing after Cesarean section | Randomized controlled clinical trial | REEDA scale (redness, edema, ecchymosis, discharge, and approximation) | 129 | [ |
| Grape seed procyanidin extract | inhibit the proinflammatory and procarcinogenic COX-2/PGE2 pathways; 15-lipoxygenase (15-LOX) | Lung cancer | Randomized controlled clinical trial | Ki67 proliferative labeling index; serum miR-19a, -19b, and -106b | 287 (146/control 141) | [ |
| Grape seed procyanidin extract | COX-2/PGE2 pathways | Lung cancer | Randomized controlled clinical trial | Serum PGE3 and leukotriene B5 (LTB5) | 287 | [ |
| Grape seed extract | Reduces TNF and IL-6 level, and TG and VLDL level decreases and HDL-C level increases. It protects against atherosclerosis | Cardiovascular prevention in obesity | Randomized, double-blinded, placebo-controlled clinical trial | visceral adiposity index (VAI), and atherogenic index of plasma (AIP); plasma LDL-C level | 50 (25/25) | [ |
| Grape seed extract | Increases glucose transport | insulin resistance in metabolic syndrome | Randomized controlled clinical trial | Plasma FBG, TG, HDL-C and insulin level | 48 (24/24) | [ |
| Red grape seed extract | Reduces TNF and IL-6 level, TG and VLDL level decreases, and HDL-C level increases. | hyperlipidaemia | Randomized controlled clinical trial | apolipoprotein AI and paraoxonase activity | 70 | [ |
Amounts of the most important active substances in grape marc (in seed and skin).
| Seed | Peel | |||
|---|---|---|---|---|
| Catechin | Epicatechin | Resveratrol | Rutin | Quercitine |
| 60–205 mg/100 g | 47–205 mg/100 g | 0.6–25 mg/100 g | 41–169 mg/100 g | 0–1.07 mg/100 g |
Percentage composition of polyphenols in grape seeds and pomace residues.
| Grape Seeds | Grape Seed Flour after Pressing | |
|---|---|---|
| Catechin | 31.5% | 47.0% |
| Procyanidin B1 | 14.0% | 15.4% |
| Procyanidin B2 | 18.5% | 10.5% |
| Epicatechin | 22.4% | 24.9% |
| Epicatechin gallate | 13.4% | 1.9% |
| Quercetin 3-O-glucuronide | 0.2% | 0.3% |